Fri, February 2, 2018

David Toung Maintained (ABBV) at Strong Buy with Increased Target to $145 on, Feb 2nd, 2018

David Toung of Argus Research, Maintained "AbbVie Inc." (ABBV) at Strong Buy with Increased Target from $120 to $145 on, Feb 2nd, 2018.

David has made no other calls on ABBV in the last 4 months.



There are 5 other peers that have a rating on ABBV. Out of the 5 peers that are also analyzing ABBV, 3 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Geoffrey Porges of "Leerink Swann" Downgraded from Buy to Hold on, Monday, January 29th, 2018
  • Marc Goodman of "UBS" Maintained at Hold with Increased Target to $95 on, Friday, October 13th, 2017
  • Geoff Meacham of "Barclays" Maintained at Hold with Increased Target to $90 on, Friday, October 13th, 2017


These are the ratings of the 2 analyists that currently disagree with David


  • Alex Arfaei of "BMO Capital" Downgraded from Hold to Sell on, Tuesday, January 30th, 2018
  • Steve Scala of "Cowen & Co." Upgraded from Hold to Buy on, Wednesday, October 11th, 2017